Xagenic Announces Second Closing of $25.5M Series B Financing
July 14, 2014Xagenic, Inc., the first company to develop a lab-free molecular diagnostic platform with a 20 minute time-to-result, announced the closing of their recently announced Series B financing, bringing their total amount raised to $25.5 million this round.
More »
Zogenix Announces New Patent Valid Through 2032 For DosePro(R) Needle-Free Delivery System
July 14, 2014Zogenix announced today the issuance of a new patent that covers the biphasic pressure profile utilized by the company’s proprietary DosePro® Needle-free Delivery System, to cover their platform in development for delivery of larger dose volumes.
More »
Ocera Therapeutics Raises $25.2 Million in Public Offering
July 10, 2014Ocera Therapeutics announced it has priced an underwritten public offering of 4,200,000 shares of common stock at an offering price of $6.00 per share. This will raise their gross proceeds to $25.2 million before deductions.
More »